Quantcast
Last updated on April 18, 2014 at 15:11 EDT

Latest Sonodynamic therapy Stories

2011-11-29 08:30:00

EDMONTON, Nov. 29, 2011 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a biotechnology company developing and commercializing products for the treatment of cancer, today announced the acceptance for publication of a research paper entitled "Antitumor Efficacy of Photodynamic Therapy Using Novel Nanoformulations of Hypocrellin Photosensitizer SL052", in the Journal of Photochemistry and Photobiology. The paper highlighted the results from a research study...

2009-03-04 11:36:00

TSX Venture: QPT EDMONTON, March 4 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company") a pharmaceutical company developing and commercializing products for the treatment of cancer and dermatological conditions, today announced results from a study designed to investigate the effectiveness of its proprietary SL052 for photodynamic therapy (PDT) used in combination with immunotherapeutic agents in solid tumor animal models. The study, conducted by Dr. Mladen...